Mount Sinai Researchers Receive NIH Grant to Study Promising Treatment for Autism Subtype

• By: Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai
• October 1st, 2013
• clinical trials, IGF-1 treatment, neurodevelopmental disorders, NIH funding, Phelan-McDermid syndrome, research, science, SHANK3 mutation, synaptic plasticity
• 1636    0

Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of autism called Phelan McDermid Syndrome (PMS). The grant...

A New Way of Thinking About Autism

• By: Eric London, MD NYS Institute for Basic Research
• July 1st, 2013
• brain biology, diagnosis, diagnostic criteria, DSM, mental health research, neurodevelopmental disorders, psychiatric diagnosis, research domain criteria
• 2352    0

On April 29, 2013 Dr. Thomas Insel, the Director of the National Institute of Mental Health (NIMH), wrote on the NIMH Director’s Blog that the Institute will be re-orienting its research away from currently used diagnostic categories (the Diagnostic and Statistical Manual or “DSM”) and...